Use of Risk Evaluation and Mitigation Strategies by the US Food and Drug Administration, 2008-2019

Jenny S. Guadamuz, Dima M. Qato, G. Caleb Alexander

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	299-301
Number of pages	3
Journal	JAMA - Journal of the American Medical Association
Volume	324
Issue number	3
DOIs	https://doi.org/10.1001/jama.2020.6611
State	Published - Jul 21 2020

ASJC Scopus subject areas

@article{8b52ac32480649c08c38f48197c9781e,

title = "Use of Risk Evaluation and Mitigation Strategies by the US Food and Drug Administration, 2008-2019",

author = "Guadamuz, {Jenny S.} and Qato, {Dima M.} and Alexander, {G. Caleb}",

year = "2020",

month = jul,

day = "21",

doi = "10.1001/jama.2020.6611",

language = "English (US)",

volume = "324",

pages = "299--301",

journal = "JAMA - Journal of the American Medical Association",

issn = "0098-7484",

publisher = "American Medical Association",

number = "3",

}

TY - JOUR

T1 - Use of Risk Evaluation and Mitigation Strategies by the US Food and Drug Administration, 2008-2019

AU - Guadamuz, Jenny S.

AU - Qato, Dima M.

AU - Alexander, G. Caleb

PY - 2020/7/21

Y1 - 2020/7/21

UR - http://www.scopus.com/inward/record.url?scp=85088607923&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85088607923&partnerID=8YFLogxK

U2 - 10.1001/jama.2020.6611

DO - 10.1001/jama.2020.6611

M3 - Letter

C2 - 32692379

AN - SCOPUS:85088607923

VL - 324

SP - 299

EP - 301

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

SN - 0098-7484

IS - 3

ER -